Superbugs and Antibiotics
Dr. Matt explains why there is a slow down in new antibiotic discovery and how the business model is different for these types of drugs. Companies are reluctant to invest in making new antibiotics because they are only prescribed for short courses and hospitals don't have to use them. This is a dangerous place to put patients, especially with the rise of superbugs.In this clip
From this podcast
The Jordan Harbinger Show
222: Matt McCarthy | The Race to Stop a Superbug Epidemic
Related Questions
Why are pharmaceuticals so expensive in the episode 222: Matt McCarthy | The Race to Stop a Superbug Epidemic and the clip Superbugs and Antibiotics?
Why is antibiotic resistance a problem as discussed in the episode 222: Matt McCarthy | The Race to Stop a Superbug Epidemic and the clip Finding Lifesaving Drugs?
Why is antibiotic resistance a problem in the episode 222: Matt McCarthy | The Race to Stop a Superbug Epidemic and the clip Superbugs Everywhere?